Screener
Praxis Precision Medicines, Inc. PRAX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s retained earnings?
- Praxis Precision Medicines, Inc. (PRAX) reported retained earnings of -$1.32B in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s retained earnings changed year-over-year?
- Praxis Precision Medicines, Inc.'s retained earnings decreased by 34.7% year-over-year, from -$977.16M to -$1.32B.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s retained earnings has grown at a 50.1% compound annual growth rate (CAGR), from -$149.55M to -$1.14B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Praxis Precision Medicines, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude